Home Behandelprotocollen CMML Richtlijnen en literatuur

Richtlijnen

Klik HIER voor de behandelrichtlijn chronische myelomonocytaire leukemie (2018) van de EHA en ELN (afgeschermd met inlog). 

Literatuur  

  1. Itzykson R. et al. Diagnosis and treatment of chronic myelomonocytic leukemias in adults: recommendations from the European Hematology Association and the European LeukemiaNet. HemaSphere 2018;2:6
  2. Arber D.A. et al. The 2016 revision of the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016 127:2391-2405
  3. Solary E. et al. How I treat CMML. Blood 2017,130;126-136
  4. Selimoglu-Buet D. et al. Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia, Blood 2015, 2015 125: 3618-3626
  5. Malcovati L et al. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. Blood 2013 122:2943-2964
  6. Itzykson R. et al. Prognostic score including gene mutations in chronic myelomonocytic leukemia. J Clin Oncol. 2013 Jul 1;31(19):2428-36
  7. Elena C. et al. Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia. Blood. 2016 Sep 8;128(10):1408-17
  8. Savona M.R. et al. An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults, Blood 2015 125: 1857-1865
  9. Symeonidis A. et al. Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation. Br. J. Haematol. 2015 Oct;171(2):239-246
  10. Such E et al. Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia. Blood 2013;121(15):3005-15
  11. Gagelmann N et al. A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantation. Blood Adv 2021;5(6):1760-9
  12. Palomo L et al. Molecular landscape and clonal architecture of adult myelodysplastic/ myeloproliferative neoplasms. Blood 2020;136(16):1851-62
  13. Mughal TI et al. An International MDS/MPN working group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/ myeloproliferative neoplasms. Haematologica 2015;100(9):1117-30
  14. Pleyer L. et al. Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study. Lancet Haematol. 2021;8(2):e135-e48

 

Ga terug naar de CMML homepage of lees meer over CMML:

Ga terug naar de algemene homepage Behandelprotocollen.